| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Oxidative Stress | 55 | 1995 | 119 |
Why?
|
Smoking | 49 | 1996 | 153 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 29 | 2002 | 25 |
Why?
|
Antioxidants | 35 | 1996 | 84 |
Why?
|
Smoke | 21 | 1995 | 20 |
Why?
|
Pneumonia | 16 | 2002 | 85 |
Why?
|
Glutathione | 39 | 1995 | 65 |
Why?
|
Histone Deacetylases | 17 | 2002 | 30 |
Why?
|
Lung | 39 | 1991 | 232 |
Why?
|
NF-kappa B | 27 | 1997 | 114 |
Why?
|
Inflammation | 25 | 2000 | 208 |
Why?
|
Oxidants | 21 | 1996 | 47 |
Why?
|
Chromatin Assembly and Disassembly | 8 | 2004 | 6 |
Why?
|
Tobacco | 14 | 1995 | 24 |
Why?
|
Sirtuin 1 | 10 | 2006 | 7 |
Why?
|
Pulmonary Alveoli | 18 | 1995 | 80 |
Why?
|
Oxidation-Reduction | 21 | 1995 | 124 |
Why?
|
Phenols | 6 | 2005 | 20 |
Why?
|
Signal Transduction | 27 | 2001 | 313 |
Why?
|
Flavonoids | 5 | 2006 | 46 |
Why?
|
Reactive Oxygen Species | 25 | 2000 | 112 |
Why?
|
Histone Deacetylase 2 | 9 | 2002 | 2 |
Why?
|
Epithelial Cells | 18 | 1996 | 135 |
Why?
|
Protein Processing, Post-Translational | 8 | 2003 | 78 |
Why?
|
Interleukin-8 | 12 | 2002 | 54 |
Why?
|
Pulmonary Emphysema | 4 | 2008 | 24 |
Why?
|
Inflammation Mediators | 9 | 2004 | 56 |
Why?
|
Histones | 10 | 2002 | 42 |
Why?
|
Glutamate-Cysteine Ligase | 15 | 1996 | 17 |
Why?
|
I-kappa B Kinase | 6 | 2006 | 26 |
Why?
|
Animals | 68 | 1991 | 1031 |
Why?
|
Bronchoalveolar Lavage Fluid | 20 | 1996 | 68 |
Why?
|
Macrophages | 7 | 2000 | 148 |
Why?
|
Epigenesis, Genetic | 6 | 2008 | 11 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 4 | 2005 | 18 |
Why?
|
Humans | 102 | 1995 | 1856 |
Why?
|
Chromatin | 5 | 2002 | 29 |
Why?
|
Lung Diseases | 5 | 2003 | 112 |
Why?
|
Acetylation | 14 | 2002 | 46 |
Why?
|
Cytokines | 7 | 2004 | 207 |
Why?
|
Repressor Proteins | 6 | 2002 | 96 |
Why?
|
Curcumin | 4 | 2005 | 11 |
Why?
|
Lipopolysaccharides | 5 | 2000 | 98 |
Why?
|
Sirtuins | 3 | 2006 | 7 |
Why?
|
Lipid Peroxidation | 15 | 1992 | 23 |
Why?
|
NF-E2-Related Factor 2 | 6 | 2004 | 15 |
Why?
|
Transcription Factor AP-1 | 8 | 1996 | 42 |
Why?
|
Anti-Inflammatory Agents | 6 | 2005 | 80 |
Why?
|
Aldehydes | 7 | 2002 | 19 |
Why?
|
Superoxide Dismutase | 7 | 1991 | 46 |
Why?
|
Poly(ADP-ribose) Polymerases | 4 | 2003 | 21 |
Why?
|
Mice | 27 | 2002 | 623 |
Why?
|
Hydrogen Peroxide | 14 | 1995 | 75 |
Why?
|
Cell Line | 23 | 1998 | 375 |
Why?
|
Mice, Knockout | 15 | 2005 | 265 |
Why?
|
Stilbenes | 3 | 2007 | 16 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2002 | 31 |
Why?
|
NADPH Oxidase | 4 | 2007 | 21 |
Why?
|
Diet | 3 | 2006 | 87 |
Why?
|
Sulfhydryl Compounds | 4 | 1996 | 42 |
Why?
|
Respiratory Mucosa | 4 | 2002 | 39 |
Why?
|
Stress, Mechanical | 2 | 2010 | 93 |
Why?
|
Asthma | 7 | 1996 | 97 |
Why?
|
Macrophages, Alveolar | 6 | 1997 | 44 |
Why?
|
Mice, Inbred C57BL | 14 | 2008 | 318 |
Why?
|
Free Radical Scavengers | 4 | 1998 | 26 |
Why?
|
Free Radicals | 7 | 1997 | 25 |
Why?
|
Endothelial Cells | 3 | 2009 | 80 |
Why?
|
Lung Neoplasms | 4 | 1998 | 159 |
Why?
|
Glutaredoxins | 4 | 2005 | 8 |
Why?
|
Transcription Factor RelA | 5 | 2006 | 36 |
Why?
|
Tumor Necrosis Factor-alpha | 10 | 1995 | 210 |
Why?
|
Monocytes | 3 | 2004 | 124 |
Why?
|
Cell Aging | 3 | 2010 | 31 |
Why?
|
Trachea | 2 | 2006 | 50 |
Why?
|
Transcription, Genetic | 5 | 1996 | 253 |
Why?
|
Bronchi | 6 | 1998 | 45 |
Why?
|
Lung Diseases, Obstructive | 3 | 1996 | 30 |
Why?
|
Infant, Premature | 2 | 2006 | 70 |
Why?
|
Endothelium, Vascular | 3 | 2003 | 139 |
Why?
|
Breath Tests | 3 | 2003 | 22 |
Why?
|
Gene Expression Regulation | 6 | 1996 | 277 |
Why?
|
Phosphorylation | 8 | 2004 | 224 |
Why?
|
Protein Carbonylation | 2 | 2010 | 4 |
Why?
|
NAD | 4 | 2010 | 41 |
Why?
|
Tobacco Smoke Pollution | 3 | 2006 | 35 |
Why?
|
Neutrophils | 10 | 1996 | 114 |
Why?
|
Glucocorticoids | 3 | 2006 | 107 |
Why?
|
Cells, Cultured | 16 | 1995 | 447 |
Why?
|
Gene Expression Regulation, Enzymologic | 5 | 2000 | 104 |
Why?
|
Emphysema | 2 | 2006 | 5 |
Why?
|
Autophagy | 2 | 2010 | 7 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2005 | 94 |
Why?
|
Casein Kinase II | 2 | 2008 | 9 |
Why?
|
Bronchopulmonary Dysplasia | 2 | 2007 | 24 |
Why?
|
Prostaglandin D2 | 3 | 2004 | 20 |
Why?
|
Polyphenols | 5 | 2006 | 9 |
Why?
|
Reactive Nitrogen Species | 2 | 2004 | 9 |
Why?
|
Nitric Oxide Synthase Type III | 2 | 2008 | 31 |
Why?
|
Forkhead Transcription Factors | 2 | 2011 | 44 |
Why?
|
Epigenomics | 1 | 2011 | 2 |
Why?
|
Dexamethasone | 2 | 1998 | 109 |
Why?
|
Hyperoxia | 3 | 1998 | 26 |
Why?
|
Azithromycin | 2 | 2007 | 13 |
Why?
|
Histone Deacetylase 1 | 1 | 2011 | 3 |
Why?
|
Genetic Predisposition to Disease | 3 | 2005 | 131 |
Why?
|
Down-Regulation | 6 | 2002 | 150 |
Why?
|
Receptors, Calcitriol | 1 | 2011 | 15 |
Why?
|
Peroxiredoxin VI | 1 | 2010 | 2 |
Why?
|
Extracellular Matrix | 2 | 2004 | 79 |
Why?
|
Matrix Metalloproteinases | 1 | 2011 | 24 |
Why?
|
Ozone | 5 | 1991 | 18 |
Why?
|
RNA, Messenger | 15 | 1991 | 394 |
Why?
|
Rheology | 1 | 2010 | 28 |
Why?
|
Up-Regulation | 4 | 2004 | 183 |
Why?
|
Drug Resistance | 1 | 2010 | 83 |
Why?
|
Isonicotinic Acids | 1 | 2010 | 2 |
Why?
|
Glutathione Disulfide | 4 | 1995 | 10 |
Why?
|
Indazoles | 1 | 2010 | 5 |
Why?
|
Gene Deletion | 1 | 2011 | 121 |
Why?
|
Apoptosis | 10 | 2000 | 265 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2009 | 23 |
Why?
|
B-Lymphocytes | 3 | 2007 | 134 |
Why?
|
Male | 30 | 1991 | 1553 |
Why?
|
Lymphocytes | 1 | 2011 | 142 |
Why?
|
Models, Biological | 7 | 2002 | 410 |
Why?
|
Acetylcysteine | 8 | 1998 | 42 |
Why?
|
Transforming Growth Factor beta | 2 | 2002 | 99 |
Why?
|
Dietary Supplements | 2 | 2006 | 34 |
Why?
|
Ubiquitination | 1 | 2008 | 10 |
Why?
|
Transcription Factor RelB | 1 | 2008 | 15 |
Why?
|
Interleukin-6 | 2 | 2007 | 145 |
Why?
|
Enzyme Inhibitors | 5 | 2000 | 216 |
Why?
|
N-Formylmethionine Leucyl-Phenylalanine | 1 | 2008 | 14 |
Why?
|
Steroids | 1 | 2008 | 38 |
Why?
|
Protein Kinase C | 1 | 2009 | 93 |
Why?
|
Adrenal Cortex Hormones | 1 | 2008 | 76 |
Why?
|
Respiratory System | 2 | 1996 | 30 |
Why?
|
Thiazolidinediones | 1 | 2008 | 35 |
Why?
|
Immunologic Factors | 1 | 2008 | 46 |
Why?
|
PPAR gamma | 2 | 2004 | 38 |
Why?
|
Hypoglycemic Agents | 1 | 2008 | 44 |
Why?
|
Proteins | 2 | 2002 | 192 |
Why?
|
Reducing Agents | 1 | 2006 | 1 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 78 |
Why?
|
Catalase | 4 | 1991 | 27 |
Why?
|
Rats | 16 | 1991 | 530 |
Why?
|
Cell Proliferation | 6 | 2005 | 227 |
Why?
|
Dose-Response Relationship, Drug | 7 | 1996 | 431 |
Why?
|
Respiration, Artificial | 1 | 2007 | 81 |
Why?
|
I-kappa B Proteins | 4 | 2000 | 33 |
Why?
|
Vitamins | 1 | 2006 | 30 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2006 | 22 |
Why?
|
Immunoblotting | 3 | 2010 | 119 |
Why?
|
Cell Cycle | 2 | 2002 | 121 |
Why?
|
Time Factors | 7 | 2002 | 896 |
Why?
|
Gene Expression | 3 | 2004 | 291 |
Why?
|
Lipid Metabolism | 1 | 2005 | 50 |
Why?
|
Chronic Disease | 5 | 2003 | 267 |
Why?
|
Membrane Glycoproteins | 1 | 2008 | 154 |
Why?
|
Biological Markers | 6 | 2003 | 262 |
Why?
|
Cell Line, Tumor | 4 | 2005 | 208 |
Why?
|
Disease Models, Animal | 5 | 2008 | 349 |
Why?
|
Ergothioneine | 1 | 2003 | 1 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 3 | 2004 | 51 |
Why?
|
Lysine | 4 | 2002 | 47 |
Why?
|
Anti-Bacterial Agents | 1 | 2007 | 195 |
Why?
|
Histone Acetyltransferases | 3 | 2002 | 20 |
Why?
|
Cyclins | 1 | 2002 | 28 |
Why?
|
Glutathione Peroxidase | 4 | 1991 | 24 |
Why?
|
Thioredoxins | 3 | 2005 | 16 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2002 | 35 |
Why?
|
Transcription Factors | 4 | 1996 | 201 |
Why?
|
Aging | 1 | 2006 | 275 |
Why?
|
Forced Expiratory Volume | 4 | 2000 | 29 |
Why?
|
Reproducibility of Results | 1 | 2004 | 391 |
Why?
|
Oxygen | 4 | 2000 | 179 |
Why?
|
Myocardial Reperfusion Injury | 2 | 2010 | 29 |
Why?
|
Transcriptional Activation | 2 | 1996 | 99 |
Why?
|
Serine | 2 | 2010 | 62 |
Why?
|
Protein Transport | 3 | 2002 | 101 |
Why?
|
Acetophenones | 1 | 1999 | 5 |
Why?
|
Infant, Newborn | 3 | 2006 | 389 |
Why?
|
Antineoplastic Agents | 1 | 2005 | 190 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2008 | 61 |
Why?
|
Pulmonary Fibrosis | 1 | 1999 | 48 |
Why?
|
Cell Count | 2 | 2007 | 163 |
Why?
|
Budesonide | 2 | 2004 | 6 |
Why?
|
Mice, Transgenic | 2 | 2010 | 209 |
Why?
|
Rats, Sprague-Dawley | 5 | 2000 | 257 |
Why?
|
Extracellular Matrix Proteins | 2 | 2004 | 45 |
Why?
|
Female | 14 | 1991 | 1643 |
Why?
|
Histone Deacetylase Inhibitors | 3 | 2002 | 17 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2005 | 224 |
Why?
|
Electron Spin Resonance Spectroscopy | 2 | 2005 | 17 |
Why?
|
Peroxiredoxins | 2 | 2005 | 3 |
Why?
|
Middle Aged | 9 | 1996 | 1161 |
Why?
|
Peroxidases | 2 | 2005 | 24 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2002 | 82 |
Why?
|
Enzyme Activation | 5 | 2002 | 177 |
Why?
|
Oxidoreductases | 2 | 2005 | 41 |
Why?
|
Cell Nucleus | 3 | 2000 | 169 |
Why?
|
Malondialdehyde | 2 | 1999 | 8 |
Why?
|
Homeostasis | 1 | 1995 | 99 |
Why?
|
Models, Chemical | 2 | 2005 | 57 |
Why?
|
Sputum | 2 | 2008 | 26 |
Why?
|
Immunohistochemistry | 3 | 2002 | 355 |
Why?
|
Treatment Outcome | 3 | 2006 | 661 |
Why?
|
Protein Synthesis Inhibitors | 4 | 1998 | 33 |
Why?
|
Cycloheximide | 4 | 1998 | 51 |
Why?
|
Ischemic Preconditioning, Myocardial | 2 | 2010 | 9 |
Why?
|
Protein Binding | 3 | 1999 | 256 |
Why?
|
Acetyltransferases | 2 | 2002 | 17 |
Why?
|
Clinical Trials as Topic | 2 | 2006 | 251 |
Why?
|
Cell Survival | 4 | 2002 | 229 |
Why?
|
Catalytic Domain | 2 | 2007 | 27 |
Why?
|
Caspases | 3 | 2000 | 58 |
Why?
|
DNA | 4 | 1999 | 262 |
Why?
|
DNA Primers | 4 | 1999 | 208 |
Why?
|
Aged | 6 | 1996 | 988 |
Why?
|
Endotoxins | 1 | 1992 | 35 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2002 | 43 |
Why?
|
Genes, Reporter | 2 | 2002 | 111 |
Why?
|
DNA-Cytosine Methylases | 1 | 2011 | 2 |
Why?
|
Histone Demethylases | 1 | 2011 | 2 |
Why?
|
Mice, 129 Strain | 1 | 2011 | 4 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2011 | 9 |
Why?
|
DNA (Cytosine-5-)-Methyltransferase | 1 | 2011 | 5 |
Why?
|
Promoter Regions, Genetic | 3 | 1996 | 188 |
Why?
|
Edema | 1 | 1992 | 67 |
Why?
|
U937 Cells | 2 | 2004 | 16 |
Why?
|
Brain Diseases | 1 | 1992 | 75 |
Why?
|
Hypertension | 2 | 2000 | 161 |
Why?
|
Heparitin Sulfate | 1 | 2010 | 6 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2010 | 5 |
Why?
|
Mice, Mutant Strains | 1 | 2011 | 77 |
Why?
|
Case-Control Studies | 3 | 1996 | 283 |
Why?
|
Metalloporphyrins | 1 | 2010 | 8 |
Why?
|
Lung Compliance | 1 | 2010 | 26 |
Why?
|
Elastin | 1 | 2010 | 22 |
Why?
|
Pancreatic Elastase | 1 | 2010 | 8 |
Why?
|
Heart Diseases | 1 | 1992 | 92 |
Why?
|
beta-Globins | 1 | 2010 | 6 |
Why?
|
Cyclic N-Oxides | 1 | 2010 | 9 |
Why?
|
Vesicular Transport Proteins | 1 | 2010 | 12 |
Why?
|
Fibroblasts | 2 | 2002 | 179 |
Why?
|
Caloric Restriction | 1 | 2010 | 6 |
Why?
|
Cell Movement | 2 | 2007 | 163 |
Why?
|
Acrolein | 1 | 2010 | 7 |
Why?
|
CREB-Binding Protein | 1 | 2010 | 9 |
Why?
|
Adipogenesis | 1 | 2010 | 9 |
Why?
|
Binding Sites | 3 | 1996 | 213 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 22 |
Why?
|
Intracellular Space | 1 | 2010 | 14 |
Why?
|
RNA, Small Interfering | 2 | 2007 | 116 |
Why?
|
Hemoglobins | 1 | 2010 | 74 |
Why?
|
Cytochrome P-450 CYP1A2 | 1 | 2010 | 4 |
Why?
|
Swine | 1 | 2010 | 95 |
Why?
|
Isoenzymes | 2 | 1991 | 144 |
Why?
|
Umbilical Veins | 1 | 2010 | 46 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2010 | 24 |
Why?
|
Leukemia, B-Cell | 1 | 2009 | 7 |
Why?
|
Cytochrome P-450 CYP1A1 | 1 | 2010 | 12 |
Why?
|
Complex Mixtures | 1 | 2010 | 8 |
Why?
|
Imidazoles | 1 | 2010 | 47 |
Why?
|
Gene Silencing | 1 | 2010 | 32 |
Why?
|
Arteritis | 1 | 2009 | 7 |
Why?
|
Thiocyanates | 1 | 2009 | 12 |
Why?
|
Heart | 1 | 2011 | 88 |
Why?
|
Tumor Cells, Cultured | 3 | 1998 | 233 |
Why?
|
Gene Targeting | 1 | 2009 | 51 |
Why?
|
Heme Oxygenase-1 | 1 | 2009 | 28 |
Why?
|
Chemokine CCL2 | 1 | 2010 | 57 |
Why?
|
Cell Division | 2 | 2002 | 273 |
Why?
|
Energy Metabolism | 1 | 2010 | 80 |
Why?
|
Water | 1 | 2010 | 85 |
Why?
|
Base Sequence | 4 | 1999 | 371 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2010 | 58 |
Why?
|
Immune System | 1 | 2010 | 43 |
Why?
|
Cell Differentiation | 2 | 2002 | 262 |
Why?
|
Animals, Newborn | 1 | 2011 | 175 |
Why?
|
Air Pollutants | 2 | 2000 | 42 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2009 | 55 |
Why?
|
Adult | 9 | 1996 | 1317 |
Why?
|
Arteries | 1 | 2009 | 56 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2007 | 135 |
Why?
|
Kinetics | 3 | 1998 | 349 |
Why?
|
Epithelium | 5 | 1996 | 101 |
Why?
|
Lymphotoxin-beta | 1 | 2008 | 7 |
Why?
|
Disease Progression | 3 | 2002 | 244 |
Why?
|
Respiratory Function Tests | 2 | 2004 | 72 |
Why?
|
Neutrophil Infiltration | 1 | 2008 | 17 |
Why?
|
Bronchial Neoplasms | 1 | 2008 | 8 |
Why?
|
Lipids | 2 | 2004 | 97 |
Why?
|
Ceramides | 1 | 2008 | 13 |
Why?
|
Peptide Fragments | 1 | 2010 | 144 |
Why?
|
Acute Disease | 1 | 2010 | 271 |
Why?
|
Mice, Inbred AKR | 1 | 2008 | 7 |
Why?
|
Deoxyguanosine | 1 | 2008 | 7 |
Why?
|
Ubiquitin | 1 | 2008 | 41 |
Why?
|
Polymorphism, Genetic | 1 | 2010 | 94 |
Why?
|
Toll-Like Receptor 4 | 1 | 2008 | 14 |
Why?
|
Macrophages, Peritoneal | 1 | 2008 | 12 |
Why?
|
Cyclooxygenase 2 | 2 | 2004 | 77 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2008 | 28 |
Why?
|
Peroxidase | 1 | 2008 | 27 |
Why?
|
Myocardium | 1 | 2010 | 119 |
Why?
|
Interleukin-1beta | 1 | 2008 | 36 |
Why?
|
Crosses, Genetic | 1 | 2008 | 47 |
Why?
|
Bronchoalveolar Lavage | 1 | 2008 | 24 |
Why?
|
Iron | 2 | 1997 | 75 |
Why?
|
Suction | 1 | 2007 | 13 |
Why?
|
Vitamin K | 2 | 1996 | 6 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2008 | 42 |
Why?
|
Aerosols | 1 | 2008 | 39 |
Why?
|
CD40 Ligand | 1 | 2008 | 51 |
Why?
|
Asbestos | 2 | 1997 | 11 |
Why?
|
Culture Media | 1 | 2008 | 116 |
Why?
|
Species Specificity | 1 | 2008 | 186 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2007 | 45 |
Why?
|
Naphthols | 1 | 2006 | 3 |
Why?
|
Tumor Necrosis Factors | 1 | 2007 | 13 |
Why?
|
Benzamides | 1 | 2006 | 11 |
Why?
|
Chemokines | 1 | 2008 | 48 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2007 | 28 |
Why?
|
Vascular Diseases | 1 | 2007 | 60 |
Why?
|
Environmental Exposure | 2 | 2005 | 75 |
Why?
|
Cell Line, Transformed | 1 | 2006 | 52 |
Why?
|
Gestational Age | 1 | 2007 | 114 |
Why?
|
Models, Immunological | 1 | 2006 | 40 |
Why?
|
Rats, Inbred Strains | 3 | 1991 | 170 |
Why?
|
Oxidants, Photochemical | 1 | 2006 | 9 |
Why?
|
Lymphoma, B-Cell | 1 | 2007 | 33 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2007 | 73 |
Why?
|
Thioredoxin-Disulfide Reductase | 1 | 2006 | 5 |
Why?
|
Leukemia, Monocytic, Acute | 1 | 2006 | 10 |
Why?
|
Spin Trapping | 1 | 2006 | 2 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2008 | 91 |
Why?
|
Angiotensin II | 1 | 2007 | 31 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2006 | 11 |
Why?
|
Oxidoreductases Acting on Sulfur Group Donors | 1 | 2005 | 3 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2006 | 14 |
Why?
|
Tars | 1 | 2005 | 1 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2006 | 13 |
Why?
|
Plants, Toxic | 2 | 1995 | 12 |
Why?
|
Spectrophotometry | 1 | 2006 | 53 |
Why?
|
Meta-Analysis as Topic | 1 | 2006 | 30 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2008 | 126 |
Why?
|
Specimen Handling | 1 | 2006 | 52 |
Why?
|
Apolipoproteins E | 1 | 2005 | 26 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 243 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2008 | 113 |
Why?
|
Muscle, Skeletal | 1 | 2010 | 114 |
Why?
|
Atherosclerosis | 1 | 2005 | 29 |
Why?
|
Superoxides | 3 | 1996 | 36 |
Why?
|
Growth Substances | 1 | 2005 | 51 |
Why?
|
Molsidomine | 1 | 2004 | 4 |
Why?
|
Chemokine CCL4 | 1 | 2004 | 16 |
Why?
|
Macrophage Inflammatory Proteins | 1 | 2004 | 17 |
Why?
|
Piperidines | 1 | 2005 | 34 |
Why?
|
Heme Oxygenase (Decyclizing) | 1 | 2006 | 18 |
Why?
|
Chemokine CXCL2 | 1 | 2004 | 29 |
Why?
|
Gene Expression Profiling | 1 | 2007 | 138 |
Why?
|
Platelet Activating Factor | 1 | 2004 | 18 |
Why?
|
Monokines | 1 | 2004 | 20 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2004 | 22 |
Why?
|
Wound Healing | 1 | 2005 | 106 |
Why?
|
Drug Interactions | 2 | 2000 | 111 |
Why?
|
Cysteine | 1 | 2005 | 52 |
Why?
|
Occupational Exposure | 1 | 2005 | 53 |
Why?
|
Annexin A1 | 1 | 2003 | 1 |
Why?
|
T-Lymphocytes | 1 | 2007 | 182 |
Why?
|
Health | 1 | 2003 | 14 |
Why?
|
Neuroprotective Agents | 1 | 2004 | 60 |
Why?
|
Molecular Structure | 1 | 2003 | 67 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2006 | 176 |
Why?
|
Membrane Lipids | 1 | 2003 | 23 |
Why?
|
Thiobarbituric Acid Reactive Substances | 2 | 1999 | 3 |
Why?
|
Neoplasms | 1 | 2010 | 239 |
Why?
|
DNA Methylation | 1 | 2002 | 29 |
Why?
|
Hydroxamic Acids | 1 | 2002 | 18 |
Why?
|
Chloramphenicol O-Acetyltransferase | 1 | 2002 | 21 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2002 | 45 |
Why?
|
Vitamin E | 2 | 1999 | 38 |
Why?
|
Adaptation, Biological | 1 | 2001 | 5 |
Why?
|
Intracellular Membranes | 2 | 1998 | 44 |
Why?
|
Response Elements | 1 | 2002 | 40 |
Why?
|
Environmental Pollutants | 1 | 2003 | 35 |
Why?
|
DNA Damage | 1 | 2003 | 66 |
Why?
|
Practice Guidelines as Topic | 1 | 2005 | 174 |
Why?
|
Liver | 2 | 1991 | 248 |
Why?
|
DNA Mutational Analysis | 1 | 2002 | 110 |
Why?
|
Phospholipids | 1 | 2002 | 52 |
Why?
|
Microscopy, Fluorescence | 1 | 2002 | 137 |
Why?
|
Lisinopril | 1 | 2000 | 2 |
Why?
|
Amlodipine | 1 | 2000 | 5 |
Why?
|
Calcium Signaling | 1 | 2003 | 52 |
Why?
|
Collagen | 1 | 2002 | 118 |
Why?
|
Body Weight | 2 | 1991 | 178 |
Why?
|
Permeability | 4 | 1996 | 52 |
Why?
|
Vital Capacity | 1 | 2000 | 25 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2000 | 34 |
Why?
|
Nitric Oxide Donors | 1 | 2000 | 11 |
Why?
|
Calcium Channel Blockers | 1 | 2000 | 48 |
Why?
|
Protein Structure, Tertiary | 1 | 2002 | 163 |
Why?
|
Polymerase Chain Reaction | 1 | 2002 | 279 |
Why?
|
Cyclic GMP | 1 | 2000 | 30 |
Why?
|
Chromans | 1 | 1999 | 14 |
Why?
|
Bronchopneumonia | 1 | 1999 | 3 |
Why?
|
Nitric Oxide Synthase | 1 | 2000 | 44 |
Why?
|
Interleukin-1 | 1 | 2000 | 109 |
Why?
|
In Situ Hybridization | 1 | 2000 | 135 |
Why?
|
Xanthine | 1 | 1998 | 4 |
Why?
|
Macrophage Migration-Inhibitory Factors | 1 | 1998 | 6 |
Why?
|
gamma-Glutamyltransferase | 1 | 1998 | 16 |
Why?
|
Eosinophils | 1 | 1998 | 30 |
Why?
|
Transfection | 1 | 2002 | 237 |
Why?
|
Severity of Illness Index | 1 | 2002 | 358 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2002 | 58 |
Why?
|
Stem Cells | 1 | 2002 | 107 |
Why?
|
Mineral Fibers | 1 | 1997 | 4 |
Why?
|
Nitric Oxide | 1 | 2000 | 85 |
Why?
|
Lipid Peroxides | 1 | 1996 | 5 |
Why?
|
Enzyme Induction | 2 | 1991 | 64 |
Why?
|
Sequence Deletion | 1 | 1996 | 88 |
Why?
|
Diagnosis, Differential | 2 | 2008 | 402 |
Why?
|
Enzymes | 1 | 1995 | 22 |
Why?
|
Blotting, Western | 2 | 2003 | 275 |
Why?
|
Recombinant Proteins | 1 | 1996 | 290 |
Why?
|
Chemotaxis | 2 | 2002 | 20 |
Why?
|
Bronchoscopy | 2 | 1999 | 27 |
Why?
|
Okadaic Acid | 2 | 2000 | 12 |
Why?
|
Atmosphere Exposure Chambers | 1 | 1992 | 14 |
Why?
|
Thiobarbiturates | 1 | 1992 | 1 |
Why?
|
Fibronectins | 2 | 2002 | 57 |
Why?
|
Leukocytes | 2 | 1999 | 94 |
Why?
|
Animals, Genetically Modified | 1 | 2011 | 29 |
Why?
|
Models, Theoretical | 1 | 2002 | 124 |
Why?
|
Plasma | 1 | 2011 | 25 |
Why?
|
Microscopy, Electron | 1 | 1992 | 178 |
Why?
|
Rats, Wistar | 2 | 1997 | 75 |
Why?
|
Particle Size | 2 | 2000 | 55 |
Why?
|
Cytosol | 1 | 2011 | 79 |
Why?
|
Shear Strength | 1 | 2009 | 13 |
Why?
|
Reference Values | 1 | 1991 | 278 |
Why?
|
Erythrocytes | 1 | 1991 | 109 |
Why?
|
Myocytes, Cardiac | 1 | 2010 | 40 |
Why?
|
Random Allocation | 1 | 2009 | 160 |
Why?
|
Genotype | 1 | 2010 | 175 |
Why?
|
Protease Inhibitors | 1 | 2008 | 39 |
Why?
|
Isoxazoles | 1 | 2007 | 15 |
Why?
|
Carcinogens | 2 | 1997 | 40 |
Why?
|
Sulfones | 1 | 2007 | 23 |
Why?
|
Neoplasm Invasiveness | 1 | 2008 | 105 |
Why?
|
Pyrazoles | 1 | 2007 | 42 |
Why?
|
DNA-Binding Proteins | 2 | 2000 | 204 |
Why?
|
Sulfonamides | 1 | 2007 | 74 |
Why?
|
Sensitivity and Specificity | 1 | 2009 | 427 |
Why?
|
Cytogenetic Analysis | 1 | 2005 | 11 |
Why?
|
Predictive Value of Tests | 1 | 2008 | 321 |
Why?
|
Lymphocyte Activation | 1 | 2007 | 137 |
Why?
|
Leukotriene E4 | 1 | 2004 | 2 |
Why?
|
Bronchial Provocation Tests | 1 | 2004 | 10 |
Why?
|
Exercise | 1 | 2006 | 82 |
Why?
|
Models, Animal | 1 | 2005 | 85 |
Why?
|
MAP Kinase Signaling System | 1 | 2005 | 56 |
Why?
|
Membrane Potentials | 1 | 2006 | 99 |
Why?
|
Collagen Type IV | 1 | 2004 | 8 |
Why?
|
Cross-Over Studies | 1 | 2004 | 82 |
Why?
|
Administration, Inhalation | 1 | 2004 | 60 |
Why?
|
Antigens, CD44 | 1 | 2004 | 18 |
Why?
|
PC12 Cells | 1 | 2004 | 27 |
Why?
|
Aged, 80 and over | 1 | 2011 | 599 |
Why?
|
Phagocytosis | 1 | 2004 | 51 |
Why?
|
Jurkat Cells | 1 | 2003 | 26 |
Why?
|
Necrosis | 1 | 2003 | 82 |
Why?
|
Cell Adhesion | 1 | 2004 | 113 |
Why?
|
Buthionine Sulfoximine | 1 | 2002 | 11 |
Why?
|
Quercetin | 1 | 2002 | 10 |
Why?
|
Gels | 1 | 2002 | 35 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 66 |
Why?
|
Beverages | 1 | 2002 | 19 |
Why?
|
Vitamin K 3 | 1 | 2002 | 4 |
Why?
|
Colony-Forming Units Assay | 1 | 2002 | 27 |
Why?
|
Analysis of Variance | 1 | 2004 | 339 |
Why?
|
Mitochondria | 1 | 2006 | 100 |
Why?
|
Antifibrinolytic Agents | 1 | 2002 | 12 |
Why?
|
Double-Blind Method | 1 | 2004 | 274 |
Why?
|
Vitamin A | 1 | 2000 | 6 |
Why?
|
Rats, Inbred WKY | 1 | 2000 | 15 |
Why?
|
Ferrozine | 1 | 2000 | 2 |
Why?
|
Risk Assessment | 1 | 2005 | 324 |
Why?
|
Polymyxin B | 1 | 2000 | 7 |
Why?
|
Blood Urea Nitrogen | 1 | 2000 | 30 |
Why?
|
Embryo, Mammalian | 1 | 2002 | 99 |
Why?
|
Rats, Inbred SHR | 1 | 2000 | 24 |
Why?
|
Deferoxamine | 1 | 2000 | 16 |
Why?
|
Trans-Activators | 1 | 2004 | 113 |
Why?
|
Serum Albumin | 1 | 2000 | 55 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2000 | 39 |
Why?
|
Neutrophil Activation | 1 | 2000 | 4 |
Why?
|
Guanylate Cyclase | 1 | 2000 | 10 |
Why?
|
Protein Isoforms | 1 | 2000 | 86 |
Why?
|
Perfusion | 1 | 2000 | 73 |
Why?
|
Triglycerides | 1 | 2000 | 48 |
Why?
|
Cholesterol | 1 | 2000 | 86 |
Why?
|
Triazoles | 1 | 2000 | 31 |
Why?
|
Technetium Tc 99m Pentetate | 1 | 1999 | 10 |
Why?
|
Radiopharmaceuticals | 1 | 1999 | 37 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1998 | 83 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1998 | 59 |
Why?
|
Drug Administration Schedule | 1 | 1998 | 191 |
Why?
|
Calcium | 1 | 2003 | 208 |
Why?
|
Adenocarcinoma | 1 | 2000 | 167 |
Why?
|
